Topical Collection on Lipid Abnormalities and Cardiovascular Prevention
In this topical collection (90 articles)
-
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Biomarkers of Plaque Instability
P. K. Shah Article:547 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Recent Advances in Visualizing Vulnerable Plaque: Focus on Noninvasive Molecular Imaging
Gezim Bala, Bernard Cosyns Article:520 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Role of the Gut in Modulating Lipoprotein Metabolism
Alan A. Hennessy, R. Paul Ross, Gerald F. Fitzgerald… Article:515 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Emerging Therapeutic Approaches to Treat Dyslipidemia
David Preiss, Chris J. Packard Article:506 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Medication Adherence in Patients with Diabetes and Dyslipidemia: Associated Factors and Strategies for Improvement
Lucas N. Marzec, Thomas M. Maddox Article:418 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Screening for and Management of Elevated Lp(a)
Michael B. Boffa, Marlys L. Koschinsky Article:417 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
How Do Elevated Triglycerides and Low HDL-Cholesterol Affect Inflammation and Atherothrombosis?
Francine K. Welty Article:400 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
Olov Wiklund, Carlo Pirazzi, Stefano Romeo Article:397 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
The Need for Combination Drug Therapies in Patients with Complex Dyslipidemia
James Barnett, Adie Viljoen, Anthony S. Wierzbicki Article:391 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Diagnosis and Management of Familial Dyslipoproteinemias
Peter O. Kwiterovich Jr. Article:371 -
Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor)
Physical Activity and Cardiorespiratory Fitness: Vital Signs for Cardiovascular Risk Assessment
Nitin Kondamudi, Anurag Mehta, Neela D. Thangada… Article:172 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Management of Lipid Abnormalities in Patients with Diabetes
Anne Sillars, Naveed Sattar Article:147 -
Lipid Abnormalities and Cardiovascular Prevention (G. De Backer, Section Editor)
Should We Use Genetic Scores in the Determination of Treatment Strategies to Control Dyslipidemias?
Katharina Lechner, Thorsten Kessler, Heribert Schunkert Article:146 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention
Lane B. Benes, Daniel J. Brandt, Eric J. Brandt… Article:138 -
Lipid Abnormalities and Cardiovascular Prevention (ED Michos, Section Editor)
A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021
Tahreem Iqbal, Michael Miller Article:111 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Progressing Insights into the Role of Dietary Fats in the Prevention of Cardiovascular Disease
Peter L. Zock, Wendy A. M. Blom, Joyce A. Nettleton… Article:111 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options
Adam N. Berman, Ron Blankstein Article:110 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium
Waqas T. Qureshi, Jamal S. Rana, Joseph Yeboah… Article:110 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
New Approaches in Detection and Treatment of Familial Hypercholesterolemia
Merel L. Hartgers, Kausik K. Ray, G. Kees Hovingh Article:109 -
Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)
Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the Future
Evan A. Stein, Frederick J. Raal Article:104
Continue reading...
To view the rest of this content please follow the download PDF link above.
